Short Abstract:

The keynote speech will provide an overview of Hamilton Medical’s main technologies, innovative strengths, and advancements. It will explore some of the latest scientific activities and trends in mechanical ventilation, including individualized therapy, PEEP-setting for ARDS patients, and strategies for spontaneous breathing patients.
Furthermore, the speech will address the challenges faced by the industry, with post-COVID impacts, stringent regulatory requirements, and the increasing burden for innovation. Approaches to overcoming these obstacles through user-centric development and rigorous validation of clinical needs, ensuring both usability and technical performance, will be discussed. Finally, the future of medical device technology will be envisioned, such as data science and machine learning to create a data-rich environment for improved patient outcomes.

Short CV:

Christoph Schranz received his Diploma in Systems Engineering from the Interstate University of Applied Sciences, Buchs, Switzerland, in 2007, and the M.Sc. degree in Biomedical Engineering from the Hochschule Furtwangen University, Germany, in 2010 and the Ph.D. degree in Medical Technology from the Technical University of Dresden, Germany in 2013. He is currently Head of New Technology within the Department of Innovation and Digitalization of Hamilton Medical AG, Switzerland and responsible for conceptualizing and developing new clinical applications in the field of mechanical ventilation.

Marc D Breton, PhD

Associate Professor of Research, University of Virginia, School of Medicine & School of Engineering and Applied Sciences, Associate Director for Research, Center for Diabetes Technology, USA

Short Abstract: TBA

Short CV:

Dr. Marc D. Breton is Professor at the University of Virginia and Associate Director and co-founder of the Center for Diabetes Technology. He received a Master of Science in Automatic Control from Ecole Centrale de Lille, France in 2001 and a PhD in System Engineering from UVa in 2004. Dr Breton’s research is centered on bringing engineering techniques such as mathematical modeling, simulation, signal processing and automatic control into the field of medicine and clinical practice, with a focus on diabetes technology, in particular the assessment and control of sugar levels in type 1 diabetes mellitus. Dr. Breton’s research is funded by the National Institute of Health, the Juvenile Diabetes Research Foundation, and Industrial partners. Dr. Breton is author of over 150 peer-reviewed publications and holds more than 20 patents in the field of diabetes technology. Dr Breton and colleagues led the academic pursuit of Automated Insulin Delivery, and designed the algorithm at the center of the Tandem t:slim with Control-IQ system. For these achievements, Dr Breton received the 2022 Artificial Pancreas Award from the Diabetes Technology Society and the 2022 Edlich-Henderson Innovator of the Year Award.

Dr. Lars Mündermann

Director & Expert - Digital Health Technology, KARL STORZ SE & Co. KG, Germany

Short Abstract: TBA

Short CV:

Short Abstract:

Virtually all forms of healthcare are experiencing demand growth which outstrips the ability of people and society to pay, increasing rationing and inequity of access to care. These changes are strongly driven by the high-intensity interaction of aging demographics and increasing chronic disease. Respiratory disease affects major portions of population and costs up to 1% GDP, conservatively or 10% of healthcare expenditure. The primary form of care mixes pharmacotherapy, some physiotherapy, and a wide range of mechanical ventilation, whether they be outpatients with COPD or ICU patients with ARDS. This talk discusses how low-cost sensors and open, low-cost device designs can liberate data from hardware, increasing inter-operability, as well as the chance to automate and optimise all three major axes of care: 1) diagnosis; 2) monitoring; and 3) care delivery – all at potentially far lower cost in clinical personnel and overall care to patients and society.

Short CV:

Professor Geoff Chase is a Distinguished Professor of Engineering at the University of Canterbury in New Zealand. His research focuses on development, validation and clinical application of physiological models, primarily in intensive care, with a focus on saving lives and cost to increase the quality and equity of access to care. He is a Fellow of the Royal Society of NZ (FRSNZ) and American Society of Mechanical Engineers (FASME), and Distinguished Fellow of Engineering NZ (DistFEngNZ) with over 1600 scientific publication and patents, and has founded 3 venture funded start-ups.